Skip to content
value.today

Nomad Health, Inc.

🇺🇸 New York, New York, USAHealth CareFounded 2015
Total raised
$73 M
4 rounds on record
Latest round
$38 M
Apr 2021
First round on record
Jul 2016
Today
Private
No later event on record

Funding rounds

4 counted as startup funding, 1 other private sales on record. Open the number of investors for the round's details.

Funding rounds of Nomad Health, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Sep 2025$34 MIssued in a merger or acquisition$10 to $50 million

Nomad Health, Inc.: Private sale, Sep 2025

Investors in this round

20 investors had bought by the notice of Dec 12, 2025: 20 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$34 M of $35 M offered; $2 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Justin Lambert · Executive Officer, Director
  • Alexander Nazem · Director
  • Brian Chee · Director
  • Garheng Kong · Director
  • Ralph Henderson · Director
  • Thomas Mawhinney · Director
  • Tom Bremner · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Justin Lambert, Chief Executive Officer. Newest notice filed Dec 12, 2025. Read the notice at the SEC.

equitySEC
Apr 2021$38 MNo. 4$10 to $50 million

Nomad Health, Inc.: Raise no. 4, Apr 2021

Investors in this round

24 investors had bought by the notice of Oct 6, 2021: 24 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$38 M of $38 M offered
Smallest investment taken
$1
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Alexander G. Nazem · Executive Officer, Director · CEO, Secretary
  • Brian Scott Chee · Director
  • Kevin G. Ryan · Director
  • Maxwell Scott Laurans · Director
  • Thomas Scott Mawhinney · Director
  • Tom Scott Bremmer · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “This filing covers the sale and issuance of Series D Preferred Stock, and the Common Stock issuable upon conversion of such Series D Preferred Stock.”

Signed by Alexander G. Nazem, Chief Executive Officer. Newest notice filed Oct 6, 2021. Read the notice at the SEC.

equitySEC
Jun 2019$20 MNo. 3$10 to $50 million

Nomad Health, Inc.: Raise no. 3, Jun 2019

Investors in this round

10 investors had bought by the notice of Aug 20, 2019: 10 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$20 M of $20 M offered
Smallest investment taken
$1
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Alexander G. Nazem · Executive Officer, Director · Chief Executive Officer, Secretary
  • Brian Scott Chee · Director
  • Chris Scott Fralic · Director
  • Kevin G. Ryan · Director
  • Maxwell Scott Laurans · Director
  • Thomas Scott Mawhinney · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “This filing covers the sale and issuance of Series C Preferred Stock, and the Common Stock issuable upon conversion of such Series C Preferred Stock.”

Signed by Alexander G. Nazem, Chief Executive Officer. Newest notice filed Aug 20, 2019. Read the notice at the SEC.

equitySEC
Feb 2018$10 MNo. 2$10 to $50 million

Nomad Health, Inc.: Raise no. 2, Feb 2018

Investors in this round

9 investors had bought by the notice of Feb 28, 2018: 9 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$10 M of $10 M offered
Smallest investment taken
$1
What was sold
equity, debt
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Alexander G. Nazem · Executive Officer, Director · Chief Executive Officer, Secretary
  • Brian G. Chee · Director
  • Chris G. Fralic · Director
  • Kevin G. Ryan · Director
  • Maxwell G. Laurans · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “This filing covers the sale and issuance of Series B Preferred Stock, the conversion of certain Convertible Promissory Notes into Series B Preferred Stock, and the Common Stock issuable upon conversion of such Series B Preferred Stock.”

Signed by Alexander G. Nazem, Chief Executive Officer. Newest notice filed Feb 28, 2018. Read the notice at the SEC.

equity, debtSEC
Jul 2016$5 MNo. 1$2 to $10 million

Nomad Health, Inc.: Raise no. 1, Jul 2016

Investors in this round

4 investors had bought by the notice of Aug 3, 2016: 4 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$5 M of $5 M offered
Smallest investment taken
$1
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Alexander G. Nazem · Executive Officer, Director · Chief Executive Officer, Secretary
  • Alexander G. Pease · Executive Officer · Vice President of Product
  • Justin G. Lambert · Executive Officer · Vice President of Business Development
  • William G. Eager · Executive Officer · Vice President of Engineering
  • Kevin G. Ryan · Director
  • Maxwell G. Laurans · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “This filing covers the sale and issuance of Series A Preferred Stock and the underlying Common Stock issuable upon conversion thereof.”

Signed by Alexander G. Nazem, Chief Executive Officer. Newest notice filed Aug 3, 2016. Read the notice at the SEC.

equitySEC

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Nomad Health, Inc. chose not to state its revenue in its newest notice of a funding round (Dec 2025).

    SEC Form D · Dec 2025

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Dec 2025

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Nomad Health, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Nomad Health, Inc.
NameRoleNamed in
Justin LambertExecutive officerDec 2025
Alexander G. NazemCEO, SecretaryOct 2021
Alexander G. PeaseVice President of ProductAug 2016
Justin G. LambertVice President of Business DevelopmentAug 2016
William G. EagerVice President of EngineeringAug 2016
Alexander NazemDirectorDec 2025
Brian CheeDirectorDec 2025
Garheng KongDirectorDec 2025
Justin LambertDirectorDec 2025
Ralph HendersonDirectorDec 2025
Thomas MawhinneyDirectorDec 2025
Tom BremnerDirectorDec 2025
Alexander G. NazemCEO, SecretaryOct 2021
Brian Scott CheeDirectorOct 2021
Kevin G. RyanDirectorOct 2021
Maxwell Scott LauransDirectorOct 2021
Thomas Scott MawhinneyDirectorOct 2021
Tom Scott BremmerDirectorOct 2021
Chris Scott FralicDirectorAug 2019
Brian G. CheeDirectorFeb 2018
Chris G. FralicDirectorFeb 2018
Maxwell G. LauransDirectorFeb 2018